Nevada AB378 establishes the Alternative Therapy Pilot Program to explore psychedelic substances for mental health treatment.
Nevada AB378 creates the Alternative Therapy Pilot Program, administered by the Division of Public and Behavioral Health. The program aims to provide access to alternative therapies involving psychedelic substances for patients diagnosed with mental health conditions. It defines "psychedelic substance" to include psilocybin, psilocin, dimethyltryptamine, ibogaine, and mescaline. The Division is tasked with developing and implementing pilot programs, collecting data, and ensuring compliance with federal and state laws.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.